Enhancing standardized diagnosis and treatment to improve the prognosis of patients with rheumatoid arthritis in China.
作者信息
Jiang Nan, Tian Xinping, Zeng Xiaofeng
机构信息
Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Beijing 100730, China.
出版信息
Rheumatol Immunol Res. 2025 Jan 9;5(4):182-185. doi: 10.1515/rir-2024-0026. eCollection 2024 Dec.
Abstract
摘要
相似文献
1
Enhancing standardized diagnosis and treatment to improve the prognosis of patients with rheumatoid arthritis in China.加强标准化诊断与治疗以改善中国类风湿关节炎患者的预后。
Rheumatol Immunol Res. 2025 Jan 9;5(4):182-185. doi: 10.1515/rir-2024-0026. eCollection 2024 Dec.
2
[To standardized the diagnosis and treatment for improve clinical outcome in patients with rheumatoid arthritis in China].[在中国规范类风湿关节炎患者的诊断与治疗以改善临床结局]
Zhonghua Nei Ke Za Zhi. 2024 Nov 1;63(11):1049-1051. doi: 10.3760/cma.j.cn112138-20240531-00361.
3
[The standardized diagnosis and treatment of rheumatoid arthritis].[类风湿关节炎的标准化诊断与治疗]
Zhonghua Nei Ke Za Zhi. 2022 Jan 1;61(1):51-59. doi: 10.3760/cma.j.cn112138-20210616-00426.
4
[2024 Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis].[2024年类风湿关节炎诊疗中国指南]
Zhonghua Nei Ke Za Zhi. 2024 Nov 1;63(11):1059-1077. doi: 10.3760/cma.j.cn112138-20240531-00360.
5
Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis.中国类风湿关节炎注册研究（CREDIT）：I. 中国类风湿关节炎患者缓解的介绍和流行率。
Clin Exp Rheumatol. 2018 Sep-Oct;36(5):836-840. Epub 2018 Mar 21.
6
A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.类风湿关节炎相关间质性肺疾病患者的临床特征和治疗管理的预测意义的回顾性研究。
Clin Rheumatol. 2020 May;39(5):1457-1470. doi: 10.1007/s10067-019-04846-1. Epub 2019 Dec 19.
7
Chinese Registry of Rheumatoid Arthritis (CREDIT) VI: Temporal Trends in Patients With Early Rheumatoid Arthritis and Moderate-To-Severe Disease Activity - A Multicenter Cohort Study of Treatment Strategies and Outcomes.中国类风湿关节炎注册研究（CREDIT）VI：早期类风湿关节炎和中重度疾病活动患者的时间趋势——治疗策略与结局的多中心队列研究
Int J Rheum Dis. 2025 Jan;28(1):e70066. doi: 10.1111/1756-185X.70066.
8
Cost-Effectiveness of Tofacitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis in China.托法替布治疗中国中重度类风湿关节炎患者的成本效果分析。
Pharmacoeconomics. 2020 Dec;38(12):1345-1358. doi: 10.1007/s40273-020-00961-z. Epub 2020 Sep 15.
9
[Recommendations for diagnosis and treatment of psoriatic arthritis in China].《中国银屑病关节炎诊疗指南》
Zhonghua Nei Ke Za Zhi. 2022 Aug 1;61(8):883-892. doi: 10.3760/cma.j.cn112138-20220103-00003.
10
Pattern and trend of five major musculoskeletal disorders in China from 1990 to 2017: findings from the Global Burden of Disease Study 2017.1990 年至 2017 年中国五大肌肉骨骼疾病的模式和趋势：来自 2017 年全球疾病负担研究的发现。
BMC Med. 2021 Feb 4;19(1):34. doi: 10.1186/s12916-021-01905-w.
本文引用的文献
1
Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.1990年至2020年全球、区域和国家类风湿性关节炎负担及到2050年的预测：全球疾病负担研究2021的系统分析
Lancet Rheumatol. 2023 Sep 25;5(10):e594-e610. doi: 10.1016/S2665-9913(23)00211-4. eCollection 2023 Oct.
2
Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients.中国类风湿关节炎注册研究（CREDIT）V：性别影响中国类风湿关节炎患者。
Chin Med J (Engl). 2022 Sep 20;135(18):2210-2217. doi: 10.1097/CM9.0000000000002110.
3
Rheumatoid arthritis: Extra-articular manifestations and comorbidities.类风湿关节炎：关节外表现及合并症
Autoimmun Rev. 2021 Apr;20(4):102776. doi: 10.1016/j.autrev.2021.102776. Epub 2021 Feb 17.
4
The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review.类风湿关节炎患者的关键合并症：一项叙述性综述。
J Clin Med. 2021 Feb 1;10(3):509. doi: 10.3390/jcm10030509.
5
Treatment satisfaction with rheumatoid arthritis in patients with different disease severity and financial burden: A subgroup analysis of a nationwide survey in China.中国全国性调查的亚组分析：不同疾病严重程度和经济负担的类风湿关节炎患者的治疗满意度。
Chin Med J (Engl). 2020 Apr 20;133(8):892-898. doi: 10.1097/CM9.0000000000000749.
6
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、地区和国家残疾调整生命年（DALYs）359 种疾病和伤害以及 195 个国家和地区 1990-2017 年的健康期望寿命（HALE）：2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3.
7
Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis.中国类风湿关节炎注册研究（CREDIT）：I. 中国类风湿关节炎患者缓解的介绍和流行率。
Clin Exp Rheumatol. 2018 Sep-Oct;36(5):836-840. Epub 2018 Mar 21.
8
Rheumatoid arthritis.类风湿关节炎。
Nat Rev Dis Primers. 2018 Feb 8;4:18001. doi: 10.1038/nrdp.2018.1.
9
Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis.中国类风湿关节炎注册研究（CREDIT）：II. 中国类风湿关节炎患者主要合并症的患病率和危险因素。
Arthritis Res Ther. 2017 Nov 15;19(1):251. doi: 10.1186/s13075-017-1457-z.
10
Sociodemographic factors associated with functional disability in outpatients with rheumatoid arthritis in Southwest China.中国西南部类风湿性关节炎门诊患者中与功能残疾相关的社会人口学因素。
Clin Rheumatol. 2015 May;34(5):845-51. doi: 10.1007/s10067-015-2896-z. Epub 2015 Feb 18.
Zotero 插件